Article
Pathogenic Autoimmunity in Atherosclerosis Evolves from HSP60-Reactive CD4 + T Cells.
Journal of cardiovascular translational research - 1 Oct 2024
Wang Shixiang, Chen Yongquan, Zhou Danyan, Zhang Jiawei, Guo Guofeng, Chen Youquan
Abstract excerpt
Clinical evidence suggests anti-Hsp60 antibodies could contribute to atherosclerosis (AS) development, with unclear mechanisms. This study aims to explore the role of anti-HSP60-mediated autoimmunity in AS progression. HSP60-MHC tetramers were used to characterize HSP60-specific CD4 + T cells and assess TCR responses in mice. These cells were transplanted into AS mice to examine immune cell differentiation and...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
